Monkeypox patients should not be left to suffer when an FDA-approved drug could help

Monkeypox patients should not be left to suffer when an FDA-approved drug could help The federal government's development of tecovirimat should be lauded as forward thinking for investing in pandemic preparedness. But its failure to use it to control the monkeypox outbreak must change. Patrick Skerrett STAT

...

We believe there is an urgent need for the federal government to simultaneously align two public health objectives: make it easier for people with monkeypox to get tecovirimat and collect high-quality data on its effectiveness.

It is important to understand the history of tecovirimat, because it represents the impressive success of U.S. government pandemic preparedness and its simultaneous failure at pandemic response...